Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013 Journal Article


Authors: Anderson, K. C.; Alsina, M.; Bensinger, W.; Biermann, J. S.; Cohen, A. D.; Devine, S.; Djulbegovic, B.; Faber, E. A. Jr; Gasparetto, C.; Hernandez-Ilizaliturri, F.; Huff, C. A.; Kassim, A.; Krishnan, A. Y.; Medeiros, B. C.; Meredith, R.; Raje, N.; Schriber, J.; Singhal, S.; Somlo, G.; Stockerl-Goldstein, K.; Treon, S. P.; Tricot, G.; Weber, D. M.; Yahalom, J.; Yunus, F.; Kumar, R.; Shead, D. A.
Article Title: Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013
Abstract: These NCCN Guidelines Insights highlight the important updates/changes specific to the management of Waldenström's Macroglobulinemia/ Lymphoplasmacytic Lymphoma. These include the addition of regimens containing novel agents as primary and salvage therapy options, inclusion of the updated summary of response categories and criteria from the sixth international workshop on Waldenström's Macroglobulinemia, and a section on management of peripheral neuropathy in the accompanying discussion. © National Comprehensive Cancer Network, Inc. 2012, All rights reserved.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 10
Issue: 10
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2012-10-01
Start Page: 1211
End Page: 1219
Language: English
PROVIDER: scopus
PUBMED: 23054875
DOI: 10.6004/jnccn.2012.0128
DOI/URL:
Notes: --- - "Export Date: 2 January 2013" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joachim Yahalom
    625 Yahalom